Oncotarget

Retraction:

Retraction: MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway

PDF  |  How to cite

Oncotarget. 2025; 16:880-880. https://doi.org/10.18632/oncotarget.28806

Metrics: PDF 32 views  |   ?  

Wei Zhou1,*, Yongfeng Li1,*, Shanmiao Gou1,*, Jiongxin Xiong1,*, Heshui Wu1, Chunyou Wang1, Haijiao Yan2, Tao Liu1,3

1 Pancreatic Disease Institute, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, P.R. China
2 Department of Oncology, the Third Affiliated Hospital of Soochow University, Changzhou, 213003, P.R. China
3 Department of Digestive Surgical Oncology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, P.R. China

Published: December 31, 2025

Copyright: © 2025 Zhou et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been retracted: Oncotarget has completed its investigation of this paper. Image forensic analysis confirmed that one panel in Figure 2C and three panels in Figure 3C were duplicated from corresponding panels in Figures 2C and 3C of reference [1], published earlier, despite representing different experiments. In addition, the miR-744 sequence shown in Figure 5A is incorrect and does not match the sequence listed in miRBase. The authors initially provided data for potential corrections; however, the extent and number of required corrections exceeded a reasonable threshold. As a result, the Editorial Decision was made to retract the publication. The National Natural Science Foundation of China Supervision Committee also confirmed misconduct, determining that the first author (Zhou Wei), second author (Li Yongfeng), and corresponding author (Liu Tao) were responsible for the identified issues. The authors agreed with the retraction.


REFERENCES

1. Wu G, Liu A, Zhu J, Lei F, Wu S, Zhang X, Ye L, Cao L, He S. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway. Oncotarget. 2015; 6:28882–94. https://doi.org/10.18632/oncotarget.4921.. [PubMed].

Original article: Oncotarget. 2015; 6:37557–37569. DOI: https://doi.org/10.18632/oncotarget.5317.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28806